Received: 12 August 2022
Accepted: 30 January 2023
First Online: 2 February 2023
: Ethics approval has been granted by the Institutional Review Board of Shengjing Hospital of China Medical University, Shenyang, China (approval number: 2021PS511K, approval date:12/05/2021). The trial protocol is in accordance with the Declaration of Helsinki. Informed consent was obtained from all study participants.
: Not applicable.
: The authors declare no competing interests.